Scarica il Dossier - Ordine dei Medici di Bologna

34. De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi E, Panella C, et al. Two new treatment
regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis 2001; 33: 67-9.
35. Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, et al. High eradication rates of Helicobacter
pylori with a new sequential treatment. Aliment Pharmacol Ther 2003; 17: 719-6.
36. Zullo A, Gatta L, De Francesco V, Hassan C, Ricci C, Bernabucci V, et al. High Helicobacter
pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled
study. Aliment Pharmacol Ther 2005; 22: 1419-24.
37. Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Boscarelli G, Piscitelli G, et al.
Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized
trial. Gastroenterology 2006; 129: 1414-1.
38. Lionetti E, Miniello VL, Castellaneta SP, Magistà AM, De Canio A, Maurogiovanni G,
et al. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in
children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006: 24: 1461-8.
39. De Francesco V, Zullo A, Margiotta M, Marangi S, Burattini O, Berloco P, et al. Sequential
treatment for Helicobacter pylori infection does not share the risk factors of triple therapy failure.
Aliment Pharmacol Ther 2004; 19: 407-14.
40. De Francesco V, Margiotta M, Zullo A, Hassan C, Troiani L, Burattini O, et al. Clarithromycin-resistant
genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006; 144:
94-100.
41. Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, Perna F, et al. Sequential therapy versus triple
therapy for Helicobacter pylori eradication: a randomized trial. Ann Int Med 2007; 146: 556-63.
42. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for
Helicobacter pylori eradication. Gut 2007; 56: 1353-57.
43. Delgado JS, Bujanda L, Gisbert JP, Titò L, Calvet X, Castro M. Effectiveness of a 10-day sequential
therapy treatment for Helicobacter pylori eradication in clinical practice. Gastroenterology
2007; 2007; 132 (Suppl 2):A112.
44. Jaffri NS,Hornung CA, Howden CW. Meta-analysis: Sequential Therapy appears superior to
standard therapy for Helicobacter pylori infection in patients Naïve to treatment. Annals of Internal
Medicine 2008; 148: on line.
45. Barry Marshall. Sequential therapy for Helicobacter pylori: A worthwhile effort for your patient.
Annals of Internal Medicine 2008; 148: on line.
46. Vakil N, Zullo A, Ricci C, Vaira D. Economic analysis and otcomes of 10-days sequential therapy
cpmpared to 10-day triple therapy for H. pylori eradication. Gastroenterology 2008; 134:
A619.
47. Cammarota G, Cianci R, Cannizzaro O, Cuoco L, Pirozzi G, Gasbarrini A, et al. Efficacy
of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.
Aliment Pharmacol Ther 2000; 14: 1339-43.
48. Cammarota G, Cianci R, Cannizzaro O, Martino A, Fedeli P, Lecca PG, et al. High-dose
versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for
Helicobacter pylori eradication. J Clin Gastroenterol 2004; 38: 110-4.
49. Zullo A, Perna F, Hassan C, Ricci C, Morini S, Vaira D. Primary antibiotic resistance in Helicobacter
pylori strains isolated in Northern and Central Italy. Aliment Pharmacol Ther 2007;
25: 1429-34.
50. Gatta L, Zullo A, Perna F, Ricci C, De Francesco V, Tampieri A, et al. A 10 days levofloxacin
base triple therapy in patients who failed two eradication courses. Aliment Pharmacol Ther
2005; 22: 45-9.
Bollettino Notiziario • Dossier 5/2008 • XIII